Sky Century Investment (SKYI) Operating Expenses (2012 - 2026)
Sky Century Investment (SKYI) posted quarterly Operating Expenses of $30392.0 for Q2 2026, down 3.4% year-over-year from $31462.0 in Q2 2025, and up 18.01% quarter-over-quarter from $25753.0 in Q1 2026.
Sky Century Investment (SKYI) Operating Expenses (2012 - 2026) Analysis & Trends
Sky Century Investment (SKYI) has reported Operating Expenses for 6 consecutive years, with $30392.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Operating Expenses fell 3.4% year-over-year to $30392.0; the TTM figure through May 2026 stood at $129246.0 (up 29.28% YoY), while the FY2025 annual figure was $141110.0, up 56.71% from the prior year.
- Operating Expenses improved to $30392.0 in Q2 2026 per SKYI's latest filing, from $25753.0 in the prior quarter.
- Across five years, Operating Expenses topped out at $50195.0 in Q3 2025 and bottomed at $9057.0 in Q3 2024.
- Historically, Operating Expenses has averaged $28846.1 across 3 years, with a median of $29726.5 in 2024.
- On a YoY basis, Operating Expenses climbed as much as 454.21% in 2025 and fell as far as 29.83% in 2025.
- Sky Century Investment's Operating Expenses stood at $30334.0 in 2024, then retreated by 24.49% to $22906.0 in 2025, then soared by 32.68% to $30392.0 in 2026.
- Business Quant data shows SKYI's Operating Expenses at $30392.0 in Q2 2026, $25753.0 in Q1 2026, and $22906.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Sky Century Investment | 393,547.71 | 393,283.71 | 26,045.00 | 30,392.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 30,392.00 |
| Feb 28, 2026 | 25,753.00 |
| Nov 30, 2025 | 22,906.00 |
| Aug 31, 2025 | 50,195.00 |
| May 31, 2025 | 31,462.00 |
| Feb 28, 2025 | 29,119.00 |
| Nov 30, 2024 | 30,334.00 |
| Aug 31, 2024 | 9,057.00 |
| May 31, 2024 | 17,743.00 |
| Feb 29, 2024 | 41,500.00 |
| Aug 31, 2014 | -8,430.00 |
| May 31, 2014 | -5,580.00 |
| Feb 28, 2014 | -4,750.00 |
| Nov 30, 2013 | -5,064.00 |
| Aug 31, 2013 | -7,875.00 |
| May 31, 2013 | -2,900.00 |
| Feb 28, 2013 | -4,200.00 |
| Nov 30, 2012 | -2,100.00 |
| Aug 31, 2012 | -7,801.00 |